What is Blockade Medical?
Headquartered in Irvine, California, Blockade Medical operates as a specialized medical device manufacturer dedicated to the endovascular management of complex neurovascular conditions. The company is primarily recognized for the development and production of the Barricade Coil System, a flagship technology designed to address ischemic and hemorrhagic strokes. By focusing on the intersection of precision engineering and clinical necessity, Blockade Medical serves a vital function in the global healthcare infrastructure, providing neurosurgeons with the tools required to manage life-threatening vascular diseases with increased efficacy and safety profiles.
How much funding has Blockade Medical raised?
Blockade Medical has raised a total of $9.2M across 3 funding rounds:
Private Equity
$5.1M
Private Equity
$1.9M
Private Equity
$2.2M
Private Equity (2011): $5.1M, investors not publicly disclosed
Private Equity (2014): $1.9M, investors not publicly disclosed
Private Equity (2015): $2.2M, investors not publicly disclosed
Key Investors in Blockade Medical
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Blockade Medical?
With the successful completion of its recent financing round, Blockade Medical is well-positioned to accelerate its research and development pipeline. The company is expected to leverage this capital to expand its market footprint, potentially scaling its manufacturing capabilities to meet the rising global demand for advanced stroke intervention technologies. Future strategic initiatives will likely focus on clinical validation studies and the potential expansion of its product portfolio, ensuring that the firm remains at the forefront of neurovascular innovation while navigating the complexities of the medical device regulatory landscape.
See full Blockade Medical company page
